ATE76411T1 - Cholecystokinin-antagonisten. - Google Patents
Cholecystokinin-antagonisten.Info
- Publication number
- ATE76411T1 ATE76411T1 AT86310226T AT86310226T ATE76411T1 AT E76411 T1 ATE76411 T1 AT E76411T1 AT 86310226 T AT86310226 T AT 86310226T AT 86310226 T AT86310226 T AT 86310226T AT E76411 T1 ATE76411 T1 AT E76411T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- aralkyl
- alkoxy
- hydroxy
- amino
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- -1 amino, hydroxy Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 102100025841 Cholecystokinin Human genes 0.000 abstract 1
- 101800001982 Cholecystokinin Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010033645 Pancreatitis Diseases 0.000 abstract 1
- 206010033647 Pancreatitis acute Diseases 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 201000003229 acute pancreatitis Diseases 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 230000036528 appetite Effects 0.000 abstract 1
- 235000019789 appetite Nutrition 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229940107137 cholecystokinin Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 208000000718 duodenal ulcer Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000001175 peptic effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/815,217 US4814463A (en) | 1985-12-31 | 1985-12-31 | CCK antagonists |
| EP86310226A EP0230151B1 (de) | 1985-12-31 | 1986-12-31 | Cholecystokinin-Antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE76411T1 true ATE76411T1 (de) | 1992-06-15 |
Family
ID=25217199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86310226T ATE76411T1 (de) | 1985-12-31 | 1986-12-31 | Cholecystokinin-antagonisten. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4814463A (de) |
| EP (1) | EP0230151B1 (de) |
| JP (1) | JPH0755927B2 (de) |
| AT (1) | ATE76411T1 (de) |
| CA (1) | CA1294737C (de) |
| DE (1) | DE3685425D1 (de) |
| ES (1) | ES2039205T3 (de) |
| GR (1) | GR3005155T3 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03503650A (ja) * | 1988-04-05 | 1991-08-15 | アボツト・ラボラトリーズ | Cckアンタゴニストとしてのトリプトファン誘導体 |
| CA1326108C (en) * | 1988-04-12 | 1994-01-11 | Sun Hyuk Kim | Cck antagonists |
| US5010089A (en) * | 1988-08-12 | 1991-04-23 | Biomeasure, Inc. | CCK antagonists and their use in treating gastrointestinal disorders |
| NZ234264A (en) * | 1989-06-29 | 1993-05-26 | Warner Lambert Co | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions |
| US5278316A (en) * | 1989-06-29 | 1994-01-11 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives |
| US5631281A (en) * | 1989-06-29 | 1997-05-20 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl α-substituted Trp-Phe- and phenethylamine derivatives |
| FR2659966B1 (fr) * | 1990-03-26 | 1992-05-22 | Rhone Poulenc Sante | Derives de n-aralkyl glycinamide, leur preparation et les medicaments les contenant. |
| FR2667066B2 (fr) * | 1990-03-07 | 1993-06-25 | Rhone Poulenc Sante | N-heterocyclyl glycinamides, leur preparation et les medicaments les contenant. |
| JPH05504968A (ja) * | 1990-03-07 | 1993-07-29 | ローン―プーラン・ロレ・ソシエテ・アノニム | グリシンアミド誘導体、その製造及びそれを含む医薬品 |
| US5264419A (en) * | 1990-08-31 | 1993-11-23 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives |
| CA2088195A1 (en) * | 1990-08-31 | 1992-03-01 | David C. Horwell | Cholecystokinin antagonists, their preparation and therapeutic use |
| US5244915A (en) * | 1990-08-31 | 1993-09-14 | Warner-Lambert Company | Amico acid derivatives cyclized at the c-terminal |
| US5593967A (en) * | 1990-08-31 | 1997-01-14 | Warner-Lambert Company | Cholecystokinin antagonists, their preparation and therapeutic use |
| AU8641991A (en) * | 1990-09-10 | 1992-03-30 | Rhone-Poulenc Rorer International (Holdings) Inc. | Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| US5239083A (en) * | 1991-03-11 | 1993-08-24 | Kyowa Hakko Kogyo Co., Ltd. | Indole derivatives which inhibit steroid 5α reductase |
| JPH06509087A (ja) * | 1991-07-05 | 1994-10-13 | メルク シヤープ エンド ドーム リミテツド | 芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用 |
| US5218123A (en) * | 1992-02-18 | 1993-06-08 | Warner-Lambert Company | Didehydrotryptophan derivatives and pharmaceutical use thereof |
| US5328927A (en) * | 1992-03-03 | 1994-07-12 | Merck Sharpe & Dohme, Ltd. | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| PL181782B1 (pl) * | 1993-08-10 | 2001-09-28 | Black James Foundation | Nowe zwiazki i sposób wytwarzania nowych zwiazków PL |
| US6403577B1 (en) | 1993-11-17 | 2002-06-11 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
| US6869957B1 (en) | 1993-11-17 | 2005-03-22 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists |
| US20060258647A1 (en) * | 2005-05-04 | 2006-11-16 | The Regents Of The University Of California | Treatment of maladaptive substance use with cholecystokinin (CCK) antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH343407A (fr) * | 1955-07-01 | 1959-12-31 | Uclaf Societe Anonyme | Procédé de préparation de peptides |
| US4000297A (en) * | 1971-05-18 | 1976-12-28 | Rotta Research Laboratorium S.P.A. | N-p-chlorobenzoyl tryptophane, salts and compositions thereof |
| DE2853825A1 (de) * | 1978-12-13 | 1980-07-03 | Troponwerke Gmbh & Co Kg | Pharmazeutisch wirksame dipeptide |
| US4356118A (en) * | 1981-06-02 | 1982-10-26 | G. D. Searle & Co. | Tryptophan derivatives |
| US4482567A (en) * | 1982-10-07 | 1984-11-13 | Research Foundation For Mental Hygiene, Inc. | N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics |
| FR2546517B1 (fr) * | 1983-05-24 | 1987-04-24 | Panmedica | Nouveaux dipeptides du -l-5-hydroxy-tryptophane, procedes pour leur preparation et medicaments les contenant |
| IT1179866B (it) * | 1984-12-12 | 1987-09-16 | Rotta Research Lab | Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono |
-
1985
- 1985-12-31 US US06/815,217 patent/US4814463A/en not_active Expired - Fee Related
-
1986
- 1986-12-26 JP JP61316007A patent/JPH0755927B2/ja not_active Expired - Lifetime
- 1986-12-30 CA CA000526443A patent/CA1294737C/en not_active Expired - Fee Related
- 1986-12-31 AT AT86310226T patent/ATE76411T1/de not_active IP Right Cessation
- 1986-12-31 DE DE8686310226T patent/DE3685425D1/de not_active Expired - Fee Related
- 1986-12-31 EP EP86310226A patent/EP0230151B1/de not_active Expired - Lifetime
- 1986-12-31 ES ES198686310226T patent/ES2039205T3/es not_active Expired - Lifetime
-
1992
- 1992-07-13 GR GR920401500T patent/GR3005155T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1294737C (en) | 1992-01-21 |
| US4814463A (en) | 1989-03-21 |
| DE3685425D1 (de) | 1992-06-25 |
| ES2039205T3 (es) | 1993-09-16 |
| EP0230151A2 (de) | 1987-07-29 |
| JPS62175461A (ja) | 1987-08-01 |
| EP0230151A3 (en) | 1989-02-01 |
| EP0230151B1 (de) | 1992-05-20 |
| JPH0755927B2 (ja) | 1995-06-14 |
| GR3005155T3 (de) | 1993-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3685425D1 (de) | Cholecystokinin-antagonisten. | |
| ES8703142A1 (es) | Proceso para preparar un derivado del bencimidazol. | |
| SE8503922D0 (sv) | Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives | |
| MY102689A (en) | 4-amino-3-carbonyl substituted quinolines | |
| DK0649418T3 (da) | 7-(2-aminoethyl)benzothiazolon | |
| WO1998058915A3 (de) | Pyrimidin-2,4,6-trion-derivate und ihre verwendung als metalloprotease-inhibitoren | |
| ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| FI964463A0 (fi) | Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina | |
| ATE92316T1 (de) | Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien. | |
| ATE113943T1 (de) | Bestimmte 3-substituierte 2-alkyl-benzofuran- derivate. | |
| PH31303A (en) | Piperazine derivatives. | |
| ATE123292T1 (de) | Cck-antagonisten. | |
| ATE46332T1 (de) | Spiro-imidazolidine als aldose-reduktaseinhibitoren. | |
| ES8802310A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas | |
| EP0205299A3 (de) | Isatinderivate, diese enthaltende Zusammensetzungen und deren Anwendung gegen Geschwüre | |
| HUP9802291A2 (hu) | Penicillamin-amid-származékok, és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| NO893039L (no) | Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler. | |
| ES479110A1 (es) | Procedimiento para preparar derivados de benzamidina. | |
| IE800900L (en) | Pyrrolidinyl-benzoic acid derivatives. | |
| HU912716D0 (en) | N,n',n'-trisubstituted 5-bis-amino-methylene-1,3-dioxane-4,6-dione derivatives and pharmaceutical preparatives containing said compounds | |
| NO171850C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-(2-pyrimidinylsulfinyl) kinolin-derivater | |
| DE69029198D1 (de) | Cholecystokinin-antagonisten | |
| JPS5283360A (en) | (e)-5-(beta-substituted vinyl)-2-thienylacetic acids | |
| ATE160567T1 (de) | Psoralen-derivate, deren herstellung und verwendung als arzneimittel | |
| DE68902626D1 (de) | Dioxopiperidinderivate enthaltende arzneimittel zur verbesserung des gedaechtnisses. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |